Atlas Trials

A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

Clinical trial NCT04067583 · COMPLETED

Trial details

NCT number
NCT04067583
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Ophthalmology, Macular Degeneration
Start date
2019-10-08
Primary completion
2020-04-15
Enrollment
454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.